title: Neuropsychiatric disorders: The choice of antipsychotics in schizophrenia.
abstract: In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs, second-generation antipsychotics have emerged as the predominant treatment for schizophrenia. A new meta-analysis concludes that the difference in efficacy between newer and older agents is small, and the current classification scheme for antipsychotics does not survive close scrutiny.
authors.affiliation: Department of Psychiatry, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore,MD 21287, USA.rmargoli@jhmi.edu
authors.forename: Russell L
authors.initials: RL
authors.lastname: Margolis
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents